Categories: News

Nexcelom Bioscience Launches the Cellaca™ MX at AACR

ATLANTA, April 1, 2019 /PRNewswire/ — Nexcelom Bioscience, a leading provider of cell counting and characterization products for the life science industry, announced the launch of the revolutionary high throughput, high-speed automated cell counter – Cellaca™ MX.

The Cellaca™ MX utilizes Nexcelom’s innovative cellular analysis technology for accurate cell sample concentration, viability and morphology measurements.  Features of the Cellaca™ MX include:

  • Brightfield and Fluorescence image cytometry
  • Cell Viability analysis using trypan blue OR fluorescent dyes
  • 24 samples imaged and processed in as quickly as 48 seconds
  • Only 25 µL cell sample required
  • 4 excitation light sources with 5 emission wavelengths for detection
  • SBS plate format
  • Automation-ready for robotic integration

According to Nexcelom CTO, Dr. Jean Qiu, the company is focused on enabling highly accurate cell counting at fast speeds in order to help accelerate other technology advancements. One such application is single-cell RNA sequencing to compare transcriptomes of single cells in determining disease mechanisms. A critical factor for successful high-quality, single-cell data is the quality of cells and the cell number per experiment. It is important to not only know the cell number and health but also the specific cell type in a heterogeneous population.  Another area that will see a huge benefit is the field of Cell Therapy.

Fast analysis for cell count and viability, using a very small amount of sample, makes Cellaca™ MX suitable for droplet-based single-cell transcriptome analysis, utilized to analyze primary samples from human and animal models.

Dr. Kristie Barth, an Immunologist at Evelo Biosciences, commented “The Cellaca™ MX has dramatically reduced sample processing time for our ex vivo preparations.  What used to take us 5 people and 7 hours, now takes us only 3 people and 4 hours to process the samples, count the cells and plate them for downstream assays.  Not only has the Cellaca™ MX saved us time and increased our efficiency, but it also has improved our sample quality.  Cells no longer sit on ice waiting to be counted, making the data output for our proteomic, genomic, and flow cytometry applications more accurate.” 

About Nexcelom: Headquartered in Lawrence, MA, Nexcelom Bioscience LLC is a manufacturer of innovative Cellometer®, Cellaca™ MX, and Celigo® image cytometry products for cell analysis. Nexcelom’s solutions automate time-consuming procedures, enabling scientists to focus less on the process and more on the research results. Contact Nexcelom Bioscience at +1 978-327-5340 or visit www.nexcelom.com

Contact: Dr. Kapil Kumar, (978) 483-8191, kkumar@nexcelom.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/nexcelom-bioscience-launches-the-cellaca-mx-at-aacr-300821303.html

SOURCE Nexcelom Bioscience

Staff

Recent Posts

Corti Unlocks “Surgical” AI Improvement, Outperforming Big Tech in Interpretability Benchmark

New "GIM" method tops MIB global leaderboard, offering the industry a scalable way to inspect…

3 hours ago

New Year’s Fitness Resolutions: Why Recovery Is the Missing Piece

HOTWORX Shares Expert Guidance on Building Sustainable Fitness Goals That Go Beyond Just Working OutNEW…

3 hours ago

Zoom Room Dog Training Partners with Fi to Bring Dog Fitness Tracking Nationwide

Leading Dog Training Franchise Expands Human Level Fitness Tracking to Select LocationsLOS ANGELES, Dec. 18,…

3 hours ago

Top CEOs, Physicians and Innovators: HIMSS26 Announces Speakers and Exclusive Executive Experience Line-up

AdventHealth's David Banks, Savannah Bananas' Tyler Gillum, AMA's John Whyte, MD, MPH and Lenox Hill…

3 hours ago

WebPT Announces Advocate Physical Therapy and Tilton’s Therapy as Winners of the 2025 Ascend Awards

Practice of the Year and Innovator of the Year honorees recognized for patient-centered care, operational…

3 hours ago

Hootan Troy Farahmand: Leading With Purpose and Compassion in Modern Healthcare

As Chief Executive Officer of Alexso, Inc., a nationwide pharmaceutical distributor, Farahmand has earned recognition…

3 hours ago